Your browser doesn't support javascript.
loading
Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial.
Cherney, David Z I; Cosentino, Francesco; Dagogo-Jack, Samuel; McGuire, Darren K; Pratley, Richard E; Frederich, Robert; Maldonado, Mario; Liu, Chih-Chin; Pong, Annpey; Cannon, Christopher P.
Afiliação
  • Cherney DZI; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Cosentino F; Unit of Cardiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • Dagogo-Jack S; University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • McGuire DK; University of Texas Southwestern Medical Center, Parkland Health and Hospital System, Dallas, Texas, USA.
  • Pratley RE; AdventHealth Translational Research Institute, Orlando, Florida, USA.
  • Frederich R; Pfizer Inc., Collegeville, Pennsylvania, USA.
  • Maldonado M; MSD Limited, London, United Kingdom.
  • Liu CC; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Pong A; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Cannon CP; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Am J Nephrol ; 53(7): 516-525, 2022.
Article em En | MEDLINE | ID: mdl-35691283
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article